4//SEC Filing
Keefe Susan 4
Accession 0001062993-22-002741
CIK 0001822691other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:01 PM ET
Size
7.9 KB
Accession
0001062993-22-002741
Insider Transaction Report
Form 4
Keefe Susan
CFO & Interim CAO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+488,466→ 488,466 totalExercise: $0.50Exp: 2029-05-10→ Common Stock (488,466 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+565,760→ 565,760 totalExercise: $0.98Exp: 2030-12-01→ Common Stock (565,760 underlying)
Footnotes (3)
- [F1]20% of the shares underlying the option vested or shall vest on June 3, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting July 3, 2020.
- [F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
- [F3]25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
Related Parties
1- filerCIK 0001399594
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:01 PM ET
- Size
- 7.9 KB